Delivery Order SPE2DB20D1004-SPE2DB25FNHWP
Award Date
6/23/25
Potential Completion Date
6/24/25
Potential Value
$7.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENQUADFI VIAL 0.5ML medical products. The $13,590.70 firm fixed price contract has a completion date of July 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MENQUADFI VIAL 0.5ML medical product. The $3,213.18 contract has a completion date of July 23, 2024 and was awarded on July 22, 2024. The contract is not designated with a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENQUADFI VIAL 0.5ML medical products. The contract has a ceiling value of $7,024.80 and an ultimate completion date of September 9, 2024. This award is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,290.75, is for the procurement of MENQUADFI VIAL 0.5ML medical supplies. The contract has an ultimate completion date of December 30, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MENQUADFI VIAL 0.5ML medical products, with a firm fixed price of $8,717.28 and a completion date of June 17, 2025. The contract is not set-aside and was awarded on June 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $7,257.70, is for the procurement of MENQUADFI VIAL 0.5ML medical products. The contract has a firm fixed price pricing type and an ultimate completion date of March 13, 2025. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $7,024.80, is for the supply of MENQUADFI VIAL 0.5ML medical products. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows the DLA to efficiently procure a comprehensive range of pharmaceutical and medical supplies...
This is a federal delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of MENQUADFI VIAL 0.5ML, a medical product, with a ceiling value of $3,927.94 and a performance period through June 13, 2025. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and holds a...
This $10,523.08 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of MENQUADFI VIAL 0.5ML medical products, with a period of performance through January 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565606323 MENQUADFI VIAL 0.5ML. The $3,444.56 firm fixed price contract has an ultimate completion date of August 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a wide range of medical commodities to support...